KFSHRC Leads With First Robotic-Assisted Retroperitoneal Lymph Node Dissection In The Middle East

The King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has reached a significant medical achievement by performing the first robotic-assisted retroperitoneal lymph node dissection in the Middle East. This procedure was conducted by the Uro-Oncology surgical team, led by Dr. Majed Al-Rumayyan, highlighting the hospital's expertise in advanced surgical care.

The patient, a man in his thirties with testicular cancer, faced a complex situation as the cancer had spread to lymph nodes near vital blood vessels like the aorta and inferior vena cava. The anatomical complexity of this area poses substantial surgical challenges, including risks of severe bleeding and nerve damage.

Dr. Al-Rumayyan explained that robotic surgery offers significant advantages over traditional methods. "One of the key advantages of robotic surgery is the considerably smaller incision compared to traditional methods," he noted. This approach resulted in minimal blood loss during and after surgery, reduced postoperative pain, and a shorter hospital stay.

The patient was discharged just one day post-operation, contrasting with the usual 5-7 days required for recovery from conventional surgery. The advanced technology allowed for precise removal of affected lymph nodes while preserving critical nerves and minimizing risks to major blood vessels.

KFSHRC has been acknowledged as a leader in healthcare both regionally and globally. It ranked first in the Middle East and Africa and 20th worldwide among the top 250 Academic Medical Centers for two consecutive years. Additionally, it was named the most valuable healthcare brand in Saudi Arabia and the Middle East by Brand Finance's 2024 rankings.

Furthermore, Newsweek magazine included KFSHRC in its World’s Best Smart Hospitals list for 2025. These accolades underscore KFSHRC's commitment to excellence and innovation in healthcare services.

The precision achieved through robotic-assisted surgery significantly reduces complications such as chylous ascites, retrograde ejaculation, venous thromboembolism, and nerve damage. This advancement demonstrates KFSHRC's dedication to enhancing patient outcomes through cutting-edge technology.

With inputs from SPA